Designation standards for orphan drugs to ease.

The designation standards for new orphan drugs seem to be adjusted more easily in the future, after revising the provision of "Regulation for orphan drug designation" to ameliorate the current provision and other designation process .

So far the orphan drugs were defined as the drug of yearly total revenue or production value at U$500 thousand or 500 million won or less, but the new provisio...